May

02

2025

Hamlet BioPharma utvald att presentera framgångsrika prekliniska och kliniska data för Alpha1H vid AACR 2025 vid American Association for Cancer Resea...

Apr

22

2025

As previously announced Hamlet BioPharma invites you to our monthly investors’ meeting to be held on the 23rd of April 2025, at 12:00. Please click on...

Apr

08

2025

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announces the publication of new sci...

Apr

08

2025

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announces the publication of new sci...

Apr

07

2025

Hamlet BioPharma’s extensive patent portfolio comprises 147 granted patents and 33 pending cases. Strategy regarding intellectual property right...

Apr

07

2025

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announces that Hamlet BioPharma’s dr...

Mar

12

2025

Som tidigare meddelats bjuder Hamlet BioPharma in till månatligt investerarmöte onsdagen den 12 mars, 2025, klockan 12.00. Klicka på länken nedan för ...

Mar

11

2025

Vid extra bolagsstämma i Hamlet BioPharma AB (publ), org.nr 556568-8958, (”Hamlet BioPharma” eller ”Bolaget”) idag den 11 mars 2025 fattades bland ann...

Feb

21

2025

Med anledning av  Pressmeddelanden och nyheter bjuder Hamlet BioPharma in till investerarmöte fredagen den 21 februari, 2025, klockan 12.00. Bolaget k...

Feb

20

2025

Aktieägarna i Hamlet BioPharma AB (publ) (”Hamlet BioPharma” eller ”Bolaget”), org.nr 556568-8958, kallas härmed till extra bolagsstämma tisdagen den ...